Skip to Main Content
50038110 Xl


ISPrime features the use of Medgene Labs' proprietary platform technology, RapidX™. This comprehensive immunological program reduces viral load and stops secondary infections. RapidX is based on our extensive bacterial isolate and viral protein construct libraries and USDA-approved vaccine components.

In addition to the RapidX's viral applications, RapidX is just as applicable to bacterial programs!

World 908894 960 720

Faster, Cheaper, Better, Safer

The technology platform behind Rapidx and ISPrime allows Medgene Labs to produce animal vaccines in less time and at a lower cost. In addition, the protein-based vaccines allow for safer, faster vaccine products that don't provide the same rapid antigenic shift, antigenic drift, drug resistance and virulence found in live and killed vaccines.


With just a few short years under our belts, Medgene Labs has developed several important patented, patent-pending and proprietary systems and products related to animal vaccines. These include:

  • Exclusive, world-wide licensed vaccine technologies for Rift Valley Fever from the Department of Homeland Security's Center of Excellence for Emerging and Zoonotic Animal Diseases.
  • A patent-pending in vitro vaccine screening system and subunit vaccine production system that leverage new USDA-CVB guidelines for licensing platform technologies.
  • Patented airborne pathogen collection system and proprietary bioinformatics approaches for disease surveillance.
  • Exclusive, world-wide license for porcine epidemic diarrhea virus spike-proteins and monoclonal antibodies.
  • Exclusive, world-wide license for vaccine adjuvants and delivery systems including InActTM, NaturprozTM, NaturmiczTM, and others.

News & Research

News & Research Monoclonal Antibodies (Purchase Form)

Documentation download to purchase monoclonal antibodies.

Read More

News & Research 5th Chinese Province infected with African Swine Fever (ASF)

African swine fever has been found again in China...

Read More